Compared with non-GLP-1 households, GLP-1 users reduced their spending by 10% over a year across 100 categories including groceries, quick-service restaurants and tobacco, according to data company Numerator
This guide covers everything, from the science of what happens inside your body when GLP-1 signaling stops, to week-by-week tapering protocols, to the exact lifestyle adjustments that separate people who maintain their results from those who do not
Human clinical evidence is limited
Koshi Hashimoto is Vice-president, Japan Endocrine Society
The market is driven by rising obesity prevalence, growing acceptance of peptide-based therapeutics, and increasing R&D investment in next-generation incretin mimetics
Treat it as a maintenance fiber to introduce gradually once your gut has settled, not a first-line choice for the acute phase